Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Once-daily gentamicin: translating theory into practice

R Cunningham1, H Humphreys

  • 1Public Health Laboratory, University Hospital, Queen's Medical Centre, Nottingham, UK.

European Journal of Clinical Pharmacology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are particle counts better than microbiological sampling to assess air supply cleanliness in operating theatres?

The Journal of hospital infection·2025
Same author

Surgery and sustainability: time for multi-disciplinary collaboration to reduce the carbon footprint while not compromising infection prevention.

The Journal of hospital infection·2025
Same author

Cold atmospheric plasma as an alternative decontaminant to control healthcare-associated infections and antimicrobial resistance - significant potential that can be realized globally.

The Journal of hospital infection·2024
Same author

Plasma-activated liquid as a potential decontaminant in healthcare: assessment of antibacterial activity and use with cleaning cloths.

The Journal of hospital infection·2024
Same author

Infection prevention and control policy implementation for CPE: a cross-sectional national survey of healthcare workers reveals knowledge gaps and suboptimal practices.

The Journal of hospital infection·2023
Same author

Cold atmospheric air plasma-activated mist as a potential decontaminant against SARS-CoV-2 surrogate in saliva.

The Journal of hospital infection·2023
Same journal

Efficacy and safety of Ensitrelvir in COVID-19 patients: a systematic review and meta-analysis with focus on viral clearance and RNA change.

European journal of clinical pharmacology·2026
Same journal

Comparing National Health Technology Assessment approaches and the new European Joint Clinical Assessment framework: The case of onco-hematological medicines.

European journal of clinical pharmacology·2026
Same journal

The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis.

European journal of clinical pharmacology·2026
Same journal

Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools.

European journal of clinical pharmacology·2026
Same journal

Efficacy and safety of doravirine/islatravir for the treatment of HIV-1: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment.

European journal of clinical pharmacology·2026
Same journal

Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin.

European journal of clinical pharmacology·2026
See all related articles

Once-daily gentamicin dosing is effective and safe for serious bacterial infections. Monitoring pre-dose concentrations below 1 mg/L is recommended until further studies clarify optimal levels for neutropenic patients.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Gentamicin remains crucial for treating severe bacterial infections.
  • Once-daily administration offers convenience over multiple daily doses.
  • Clinical data support the efficacy and safety of once-daily gentamicin for various infections.

Purpose of the Study:

  • To evaluate the current understanding and unresolved issues regarding once-daily gentamicin administration.
  • To address concerns about serum concentration monitoring in once-daily dosing regimens.
  • To provide guidance on pre-dose concentration targets for once-daily gentamicin therapy.

Main Methods:

  • Review of animal studies and clinical trials on once-daily gentamicin.
  • Analysis of challenges in therapeutic drug monitoring (TDM) for once-daily dosing.

Related Experiment Videos

  • Discussion of current recommendations and areas needing further research.

    • Main Results:

    • Once-daily gentamicin is as effective and safe as multiple daily doses for many infections.
    • Assay systems often lack sensitivity for low pre-dose concentrations in once-daily regimens.
    • An acceptable pre-dose concentration target is not definitively established, with <1 mg/L suggested as prudent.

    Conclusions:

    • Once-daily gentamicin administration is likely to become standard practice due to its advantages.
    • Further research is needed to refine serum concentration monitoring for once-daily gentamicin.
    • Careful consideration of assay methods and pre-dose targets is necessary, especially for neutropenic patients.